SMC approves new drug combination for use by NHS Scotland
On 10 March 2025, the Scottish Medicines Consortium (SMC) approved Talazoparib (brand name Talzenna®), in combination with enzalutamide, for use […]
On 10 March 2025, the Scottish Medicines Consortium (SMC) approved Talazoparib (brand name Talzenna®), in combination with enzalutamide, for use […]
Our West Lothian group were in Asda Livingston recently, raising awareness of prostate cancer and collecting funds as part of […]
The group held its first outing of 28th February 2025. The walk was led by Rob Lester, who took us […]